CellaVision AB (publ) 0MR5.IL Stock
CellaVision AB (publ) Price Chart
CellaVision AB (publ) 0MR5.IL Financial and Trading Overview
CellaVision AB (publ) stock price | 221 SEK |
Previous Close | 195.3 SEK |
Open | 199 SEK |
Bid | 191.2 SEK x 0 |
Ask | 205 SEK x 0 |
Day's Range | 199 - 199 SEK |
52 Week Range | 153 - 388.63 SEK |
Volume | 20 SEK |
Avg. Volume | 3.23K SEK |
Market Cap | 4.75B SEK |
Beta (5Y Monthly) | 0.995402 |
PE Ratio (TTM) | 43.544857 |
EPS (TTM) | 3.91 SEK |
Forward Dividend & Yield | 2.25 (1.14%) |
Ex-Dividend Date | May 9, 2023 |
1y Target Est | N/A |
0MR5.IL Valuation Measures
Enterprise Value | 4.67B SEK |
Trailing P/E | 43.544857 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 7.705098 |
Price/Book (mrq) | 7.1451654 |
Enterprise Value/Revenue | 7.585 |
Enterprise Value/EBITDA | 30.078 |
Trading Information
CellaVision AB (publ) Stock Price History
Beta (5Y Monthly) | 0.995402 |
52-Week Change | -34.97% |
S&P500 52-Week Change | 20.43% |
52 Week High | 388.63 SEK |
52 Week Low | 153 SEK |
50-Day Moving Average | 184.3 SEK |
200-Day Moving Average | 227.77 SEK |
0MR5.IL Share Statistics
Avg. Volume (3 month) | 3.23K SEK |
Avg. Daily Volume (10-Days) | 1.33K SEK |
Shares Outstanding | 23.85M |
Float | 19.52M |
Short Ratio | N/A |
% Held by Insiders | 38.15% |
% Held by Institutions | 41.54% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 2.25 |
Trailing Annual Dividend Yield | 1.15% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.48080003 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 16.09% |
Operating Margin (ttm) | 21.66% |
Gross Margin | 68.10% |
EBITDA Margin | 25.21% |
Management Effectiveness
Return on Assets (ttm) | 9.55% |
Return on Equity (ttm) | 15.87% |
Income Statement
Revenue (ttm) | 616.01M SEK |
Revenue Per Share (ttm) | 25.83 SEK |
Quarterly Revenue Growth (yoy) | -14.39% |
Gross Profit (ttm) | 438.32M SEK |
EBITDA | 155.35M SEK |
Net Income Avi to Common (ttm) | 99.14M SEK |
Diluted EPS (ttm) | 4.57 |
Quarterly Earnings Growth (yoy) | -50.00000000000000000000000000000000% |
Balance Sheet
Total Cash (mrq) | 93.07M SEK |
Total Cash Per Share (mrq) | 3.9 SEK |
Total Debt (mrq) | 95.62M SEK |
Total Debt/Equity (mrq) | 14.4 SEK |
Current Ratio (mrq) | 3.018 |
Book Value Per Share (mrq) | 27.851 |
Cash Flow Statement
Operating Cash Flow (ttm) | 117.96M SEK |
Levered Free Cash Flow (ttm) | 2.56M SEK |
Profile of CellaVision AB (publ)
Country | United Kingdom |
State | N/A |
City | Lund |
Address | Mobilvägen 12 |
ZIP | 223 62 |
Phone | 46 4 64 60 16 00 |
Website | https://www.cellavision.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 235 |
CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears and body fluid preparations; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears. It also offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; CellaVision Body Fluid Application that enables laboratories to automate, standardize, and simplify morphological examination of body fluid preparations; and CellaVision Remote Review Software, which removes restrictive geographical constraints from the smear review process. In addition, the company provides CellaVision Server Software that creates a single streamlined workflow within one or multiple testing sites; CellaVision Proficiency Software, a cloud-based software designed to help laboratory managers assess, monitor, and promote staff competency in cell morphology; CellaVision CellAtlas, which combines a series of mini lectures with an extensive cell image library; and CellaVision VET that offers digital solutions for medical microscopy in the field of hematology. Further, it offers reagents to identify cell and tissue morphology, parasites, and bacteria in diagnosing various diseases; and instruments, including RAL SmearBox, RAL Stainbox, and RAL Stainer. The company sells its products to hospital and commercial laboratories. The company was incorporated in 1994 and is headquartered in Lund, Sweden.
Q&A For CellaVision AB (publ) Stock
What is a current 0MR5.IL stock price?
CellaVision AB (publ) 0MR5.IL stock price today per share is 221 SEK.
How to purchase CellaVision AB (publ) stock?
You can buy 0MR5.IL shares on the IOB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CellaVision AB (publ)?
The stock symbol or ticker of CellaVision AB (publ) is 0MR5.IL.
Which industry does the CellaVision AB (publ) company belong to?
The CellaVision AB (publ) industry is Medical Devices.
How many shares does CellaVision AB (publ) have in circulation?
The max supply of CellaVision AB (publ) shares is 29.43M.
What is CellaVision AB (publ) Price to Earnings Ratio (PE Ratio)?
CellaVision AB (publ) PE Ratio is 56.52173600 now.
What was CellaVision AB (publ) earnings per share over the trailing 12 months (TTM)?
CellaVision AB (publ) EPS is 3.91 SEK over the trailing 12 months.
Which sector does the CellaVision AB (publ) company belong to?
The CellaVision AB (publ) sector is Healthcare.